Correlation Between Argenx NV and Immutep
Can any of the company-specific risk be diversified away by investing in both Argenx NV and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Argenx NV and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between argenx NV ADR and Immutep Limited, you can compare the effects of market volatilities on Argenx NV and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Argenx NV with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Argenx NV and Immutep.
Diversification Opportunities for Argenx NV and Immutep
Very good diversification
The 3 months correlation between Argenx and Immutep is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding argenx NV ADR and Immutep Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Limited and Argenx NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on argenx NV ADR are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Limited has no effect on the direction of Argenx NV i.e., Argenx NV and Immutep go up and down completely randomly.
Pair Corralation between Argenx NV and Immutep
Given the investment horizon of 90 days argenx NV ADR is expected to generate 0.75 times more return on investment than Immutep. However, argenx NV ADR is 1.33 times less risky than Immutep. It trades about 0.15 of its potential returns per unit of risk. Immutep Limited is currently generating about -0.04 per unit of risk. If you would invest 51,423 in argenx NV ADR on November 2, 2024 and sell it today you would earn a total of 15,145 from holding argenx NV ADR or generate 29.45% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
argenx NV ADR vs. Immutep Limited
Performance |
Timeline |
argenx NV ADR |
Immutep Limited |
Argenx NV and Immutep Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Argenx NV and Immutep
The main advantage of trading using opposite Argenx NV and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Argenx NV position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.Argenx NV vs. Blueprint Medicines Corp | Argenx NV vs. Amylyx Pharmaceuticals | Argenx NV vs. Day One Biopharmaceuticals | Argenx NV vs. Terns Pharmaceuticals |
Immutep vs. Zura Bio Limited | Immutep vs. Enveric Biosciences | Immutep vs. Immix Biopharma | Immutep vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamental Analysis View fundamental data based on most recent published financial statements |